Honliv Healthcare
Honliv Healthcare, headquartered in China, is a prominent player in the healthcare industry, specialising in the development and manufacturing of high-quality medical devices and healthcare solutions. Founded in 2003, the company has established a strong presence in major operational regions across Asia and beyond, focusing on innovative products that enhance patient care. With a diverse portfolio that includes advanced wound care products, surgical instruments, and diagnostic equipment, Honliv Healthcare stands out for its commitment to quality and innovation. The company has achieved significant milestones, including various certifications and partnerships that underscore its market position. Recognised for its dedication to improving healthcare outcomes, Honliv Healthcare continues to lead the way in delivering effective and reliable medical solutions.
DitchCarbon Score
How does Honliv Healthcare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Honliv Healthcare's score of 23 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Honliv Healthcare's reported carbon emissions
In 2023, Honliv Healthcare reported total carbon emissions of approximately 10,441,880 kg CO2e. This figure includes about 2,772,960 kg CO2e from Scope 1 emissions and approximately 7,668,920 kg CO2e from Scope 2 emissions. Compared to 2022, where total emissions were about 11,520,710 kg CO2e, this marks a significant reduction in emissions. In 2022, the company’s Scope 1 emissions were approximately 2,871,310 kg CO2e, and Scope 2 emissions were about 8,649,400 kg CO2e. The trend shows a decrease in both scopes over the years, with 2021 emissions at about 10,540,210 kg CO2e, which included approximately 3,212,250 kg CO2e from Scope 1 and about 7,327,960 kg CO2e from Scope 2. Despite these reductions, Honliv Healthcare has not disclosed any specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The absence of Scope 3 emissions data indicates a potential area for future reporting and improvement. Overall, Honliv Healthcare demonstrates a commitment to reducing its carbon footprint, aligning with industry standards for climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 3,003,540 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 5,075,910 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Honliv Healthcare is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
